Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Sorafenib improves progression-free survival for patients with rare sarcomas

europeanpharmaceuticalreviewApril 03, 2018

Tag: sorafenib tosylate , progression-free survival , fibromatosis , Nexavar , tumours

PharmaSources Customer Service